Iron oxide nanoparticles may help detect, treat tumors

May 1, 2006

A new technique devised by MIT engineers may one day help physicians detect cancerous tumors during early stages of growth. The technique allows nanoparticles to group together inside cancerous tumors, creating masses with enough of a magnetic signal to be detectable by a magnetic resonance imaging (MRI) machine.

The work appears as the cover feature in the May issue of Angewandte Chemie International Edition, one of the world's leading chemistry journals.

The research, which is just moving into animal testing, involves injecting nanoparticles made of iron oxide into the body, where they flow through the bloodstream and enter tumors.

Solid tumors must form new blood vessels to grow. But because this growth is so rapid in cancerous tumors, there are gaps in the endothelial cells that line the inside of the blood vessels. The nanoparticles can slip through these gaps to enter the tumors.

Once inside the tumor, the nanoparticles can be triggered to group together by a mechanism designed by the MIT engineers. Specifically, certain enzymes, or proteases, inside the tumors cause the nanoparticles to "self-assemble" or stick together. The resulting nanoparticle clumps are too big to get back out of the gaps. Further, the clumps have a stronger magnetic signal than do individual nanoparticles, allowing detection by MRI.

"We inject nanoparticles that will self-assemble when they are exposed to proteases inside of invasive tumors," said Sangeeta N. Bhatia, M.D., Ph.D., associate professor of the Harvard-MIT Division of Health Sciences & Technology (HST) and Electrical Engineering and Computer Science (EECS). "When they assemble they should get stuck inside the tumor and be more visible on an MRI. This might allow for noninvasive imaging of fast-growing cancer 'hot spots' in tumors." Bhatia also is affiliated with the MIT-Harvard Center of Cancer Nanotechnology Excellence.

The technique initially is being used to study breast tumors. Bhatia added that it eventually may be applied to many different types of cancers and to study the "triggers" that turn a benign mass in the body into a cancerous tumor. Nanoparticles also hold the promise of carrying medicines that could kill cancer cells, replacing radiation or chemotherapy treatments that cause negative side effects such as hair loss or nausea.

The researchers hold a provisional patent on their work.

Source: MIT

Explore further: Nanocarriers may carry new hope for brain cancer therapy

Related Stories

Nanocarriers may carry new hope for brain cancer therapy

November 19, 2015

Glioblastoma multiforme, a cancer of the brain also known as "octopus tumors" because of the manner in which the cancer cells extend their tendrils into surrounding tissue, is virtually inoperable, resistant to therapies, ...

Study could impact noninvasive treatment of cancer tumors

June 14, 2007

Ram Devireddy, assistant professor of mechanical engineering at LSU, recently co-authored an article with Todd Monroe, assistant professor of biological and agricultural engineering, investigating the complex effects of nanoparticles ...

Implant monitors tumors

May 13, 2009

Surgical removal of a tissue sample is now the standard for diagnosing cancer. Such procedures, known as biopsies, are accurate but only offer a snapshot of the tumor at a single moment in time.

Attacking cancer cells with nanoparticles

October 25, 2011

( -- About every three days, Colleen Alexander, a chemistry graduate student, feeds cells that cause a deadly type of brain cancer. It’s a ritual that involves assessing the health of the cells under a microscope, ...

Recommended for you


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.